07:51 AM EST, 11/13/2025 (MT Newswires) -- Arbutus Biopharma ( ABUS ) on Thursday reported a Q3 net loss of $0.04 per diluted share, narrower than a loss of $0.10 a year earlier.

Four analysts polled by FactSet expected a loss of $0.03.

Revenue for the quarter ended Sept. 30 was $529,000, down from $1.3 million a year earlier.

Three analysts surveyed by FactSet expected $1.3 million.

As of Sept. 30, the company said it had $93.7 million in cash and or cash equivalents on hand.